Pacira Pharmaceuticals shares owned by Two Sigma Investments
Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Two Sigma Investments
from 13F filings
Historical chart of Two Sigma Investments investment in Pacira Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Pacira Pharmaceuticals held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pacira Pharmaceuticals by Two Sigma Investments
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.0M | 233k | 25.77 |
| 2025-06-30 | $2.6M | 107k | 23.90 |
| 2025-03-31 | $2.9M | 118k | 24.85 |
| 2024-12-31 | $2.2M | 115k | 18.84 |
| 2024-09-30 | $1.0M | 70k | 15.05 |
| 2024-06-30 | $2.2M | 76k | 28.61 |
| 2024-03-31 | $3.2M | 110k | 29.22 |
| 2023-12-31 | $1.2M | 36k | 33.74 |
| 2023-09-30 | $3.0M | 97k | 30.68 |
| 2023-06-30 | $5.7M | 143k | 40.07 |
| 2023-03-31 | $1.0M | 25k | 40.81 |
| 2022-03-31 | $1.3M | 18k | 76.33 |
| 2021-12-31 | $4.1M | 68k | 60.17 |
| 2021-09-30 | $6.2M | 110k | 56.00 |
| 2021-06-30 | $22M | 366k | 60.68 |
| 2021-03-31 | $6.2M | 88k | 70.09 |
| 2020-12-31 | $5.0M | 83k | 59.84 |
| 2020-09-30 | $8.8M | 147k | 60.12 |
| 2020-03-31 | $1.3M | 40k | 33.52 |
| 2019-12-31 | $6.0M | 132k | 45.30 |
| 2019-06-30 | $12M | 274k | 43.49 |
| 2019-03-31 | $7.5M | 198k | 38.06 |
| 2018-12-31 | $12M | 286k | 43.02 |
| 2018-09-30 | $8.5M | 174k | 49.15 |
| 2017-12-31 | $7.4M | 162k | 45.65 |
| 2017-09-30 | $2.1M | 55k | 37.55 |
| 2017-06-30 | $13M | 272k | 47.70 |
| 2017-03-31 | $11M | 240k | 45.60 |
| 2016-12-31 | $7.7M | 239k | 32.30 |
| 2016-09-30 | $6.1M | 179k | 34.22 |
| 2016-06-30 | $7.1M | 210k | 33.73 |
| 2016-03-31 | $3.4M | 64k | 52.97 |
| 2015-12-31 | $857k | 11k | 76.79 |
| 2015-09-30 | $699k | 17k | 41.08 |
| 2014-09-30 | $22M | 229k | 96.92 |
| 2014-06-30 | $7.2M | 79k | 91.86 |
| 2014-03-31 | $3.7M | 53k | 69.99 |
| 2012-03-31 | $520k | 45k | 11.56 |
| 2011-12-31 | $330k | 38k | 8.64 |